Dolby Laboratories, Inc.

For the period ended Mar 27, 2026. Filed Apr 30, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 27, 2026 · Filed Apr 30, 2026

DLB$64.67-0.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Unaudited Interim Condensed Consolidated Balance Sheets

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts)

	March 27,2026	September 26,2025
ASSETS
Current assets:
Cash and cash equivalents	$594,282	$701,893
Restricted cash	79,523	91,468
Short-term investments	460	703
Accounts receivable, net of allowance for credit losses of $10,140 and $7,221	391,293	331,096
Contract assets, net of allowance for credit losses of $83 and $101	238,924	180,804
Inventories, net	31,929	30,424
Prepaid expenses and other current assets	78,298	51,873
Total current assets	1,414,709	1,388,261
Long-term investments	81,220	80,205
Property, plant, and equipment, net	461,841	470,608
Operating lease right-of-use assets	44,759	33,204
Intangible assets, net	389,709	397,057
Goodwill	529,669	529,900
Deferred taxes	209,321	214,361
Other non-current assets	118,266	114,164
Total assets	$3,249,494	$3,227,760
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$20,688	$17,840
Accrued liabilities	405,200	369,256
Income taxes payable	15	8,928
Contract liabilities	38,837	31,382
Operating lease liabilities	9,866	10,384
Total current liabilities	474,606	437,790
Non-current contract liabilities	24,084	29,687
Non-current operating lease liabilities	39,826	28,494
Other non-current liabilities	83,846	99,843
Total liabilities	622,362	595,814
Commitments and Contingencies (See Note 15)
Stockholders’ equity:
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 60,338,707 shares issued and outstanding as of March 27, 2026 and 60,802,616 as of September 26, 2025	53	54
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 34,251,901 shares issued and outstanding as of March 27, 2026 and 34,660,045 as of September 26, 2025	40	40
Retained earnings	2,630,175	2,634,980
Accumulated other comprehensive loss	(12,276)	(12,517)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,617,992	2,622,557
Noncontrolling interest	9,140	9,389
Total stockholders’ equity	2,627,132	2,631,946
Total liabilities and stockholders’ equity	$3,249,494	$3,227,760

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.